Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus

Gautham Ravipati, Wilbert S. Aronow, Chul Ahn, Kumbar Sujata, Leonardo N. Saulle, Venu Channamsetty, Melvin B. Weiss

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Coronary angiography was performed in 152 men and 163 women with diabetes mellitus, mean age 55 ± 8 years, because of chest pain. Of 67 patients with 3-vessel or 4-vessel coronary artery disease (CAD), 17 (25%) were treated with diet alone, 29 (43%) with insulin, 18 (27%) with sulfonylureas, 12 (18%) with metformin, and 6 (9%) with thiazolidinediones. Of 76 patients with 2-vessel CAD, 20 (26%) were treated with diet alone, 36 (47%) with insulin, 21 (28%) with sulfonylureas, 21 (28%) with metformin, and 11 (14%) with thiazolidinediones. Of 40 patients with 1-vessel CAD, 15 (38%) were treated with diet alone, 11 (28%) with insulin, 8 (20%) with sulfonylureas, 12 (30%) with metformin, and 4 (10%) with thiazolidinediones. Of 132 patients with 0-vessel CAD, 18 (14%) were treated with diet alone, 21 (16%) with insulin, 7 (5%) with sulfonylureas, 75 (56%) with metformin, and 35 (26%) with thiazolidinediones. Cochran-Armitage trend tests were used to examine whether the use of treatment significantly increases or decreases as the number of arteries with CAD increases (P = 0.036 for diet alone; P < 0.0001 for insulin, for sulfonylureas, and for metformin; P = 0.002 for thiazolidinediones).

Original languageEnglish (US)
Pages (from-to)400-403
Number of pages4
JournalAmerican Journal of Therapeutics
Volume13
Issue number5
DOIs
StatePublished - Sep 2006

Fingerprint

Thiazolidinediones
Metformin
Coronary Artery Disease
Diabetes Mellitus
Insulin
Diet
Coronary Angiography
Chest Pain
Arteries

Keywords

  • Coronary artery disease
  • Diabetes mellitus
  • Diet
  • Insulin
  • Metformin
  • Sulfonylureas
  • Thiazolidinediones

ASJC Scopus subject areas

  • Pharmacology

Cite this

Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus. / Ravipati, Gautham; Aronow, Wilbert S.; Ahn, Chul; Sujata, Kumbar; Saulle, Leonardo N.; Channamsetty, Venu; Weiss, Melvin B.

In: American Journal of Therapeutics, Vol. 13, No. 5, 09.2006, p. 400-403.

Research output: Contribution to journalArticle

Ravipati, Gautham ; Aronow, Wilbert S. ; Ahn, Chul ; Sujata, Kumbar ; Saulle, Leonardo N. ; Channamsetty, Venu ; Weiss, Melvin B. / Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus. In: American Journal of Therapeutics. 2006 ; Vol. 13, No. 5. pp. 400-403.
@article{f81c38020e23406698ef2f6f458e348c,
title = "Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus",
abstract = "Coronary angiography was performed in 152 men and 163 women with diabetes mellitus, mean age 55 ± 8 years, because of chest pain. Of 67 patients with 3-vessel or 4-vessel coronary artery disease (CAD), 17 (25{\%}) were treated with diet alone, 29 (43{\%}) with insulin, 18 (27{\%}) with sulfonylureas, 12 (18{\%}) with metformin, and 6 (9{\%}) with thiazolidinediones. Of 76 patients with 2-vessel CAD, 20 (26{\%}) were treated with diet alone, 36 (47{\%}) with insulin, 21 (28{\%}) with sulfonylureas, 21 (28{\%}) with metformin, and 11 (14{\%}) with thiazolidinediones. Of 40 patients with 1-vessel CAD, 15 (38{\%}) were treated with diet alone, 11 (28{\%}) with insulin, 8 (20{\%}) with sulfonylureas, 12 (30{\%}) with metformin, and 4 (10{\%}) with thiazolidinediones. Of 132 patients with 0-vessel CAD, 18 (14{\%}) were treated with diet alone, 21 (16{\%}) with insulin, 7 (5{\%}) with sulfonylureas, 75 (56{\%}) with metformin, and 35 (26{\%}) with thiazolidinediones. Cochran-Armitage trend tests were used to examine whether the use of treatment significantly increases or decreases as the number of arteries with CAD increases (P = 0.036 for diet alone; P < 0.0001 for insulin, for sulfonylureas, and for metformin; P = 0.002 for thiazolidinediones).",
keywords = "Coronary artery disease, Diabetes mellitus, Diet, Insulin, Metformin, Sulfonylureas, Thiazolidinediones",
author = "Gautham Ravipati and Aronow, {Wilbert S.} and Chul Ahn and Kumbar Sujata and Saulle, {Leonardo N.} and Venu Channamsetty and Weiss, {Melvin B.}",
year = "2006",
month = "9",
doi = "10.1097/01.mjt.0000208276.65249.1b",
language = "English (US)",
volume = "13",
pages = "400--403",
journal = "American Journal of Therapeutics",
issn = "1075-2765",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus

AU - Ravipati, Gautham

AU - Aronow, Wilbert S.

AU - Ahn, Chul

AU - Sujata, Kumbar

AU - Saulle, Leonardo N.

AU - Channamsetty, Venu

AU - Weiss, Melvin B.

PY - 2006/9

Y1 - 2006/9

N2 - Coronary angiography was performed in 152 men and 163 women with diabetes mellitus, mean age 55 ± 8 years, because of chest pain. Of 67 patients with 3-vessel or 4-vessel coronary artery disease (CAD), 17 (25%) were treated with diet alone, 29 (43%) with insulin, 18 (27%) with sulfonylureas, 12 (18%) with metformin, and 6 (9%) with thiazolidinediones. Of 76 patients with 2-vessel CAD, 20 (26%) were treated with diet alone, 36 (47%) with insulin, 21 (28%) with sulfonylureas, 21 (28%) with metformin, and 11 (14%) with thiazolidinediones. Of 40 patients with 1-vessel CAD, 15 (38%) were treated with diet alone, 11 (28%) with insulin, 8 (20%) with sulfonylureas, 12 (30%) with metformin, and 4 (10%) with thiazolidinediones. Of 132 patients with 0-vessel CAD, 18 (14%) were treated with diet alone, 21 (16%) with insulin, 7 (5%) with sulfonylureas, 75 (56%) with metformin, and 35 (26%) with thiazolidinediones. Cochran-Armitage trend tests were used to examine whether the use of treatment significantly increases or decreases as the number of arteries with CAD increases (P = 0.036 for diet alone; P < 0.0001 for insulin, for sulfonylureas, and for metformin; P = 0.002 for thiazolidinediones).

AB - Coronary angiography was performed in 152 men and 163 women with diabetes mellitus, mean age 55 ± 8 years, because of chest pain. Of 67 patients with 3-vessel or 4-vessel coronary artery disease (CAD), 17 (25%) were treated with diet alone, 29 (43%) with insulin, 18 (27%) with sulfonylureas, 12 (18%) with metformin, and 6 (9%) with thiazolidinediones. Of 76 patients with 2-vessel CAD, 20 (26%) were treated with diet alone, 36 (47%) with insulin, 21 (28%) with sulfonylureas, 21 (28%) with metformin, and 11 (14%) with thiazolidinediones. Of 40 patients with 1-vessel CAD, 15 (38%) were treated with diet alone, 11 (28%) with insulin, 8 (20%) with sulfonylureas, 12 (30%) with metformin, and 4 (10%) with thiazolidinediones. Of 132 patients with 0-vessel CAD, 18 (14%) were treated with diet alone, 21 (16%) with insulin, 7 (5%) with sulfonylureas, 75 (56%) with metformin, and 35 (26%) with thiazolidinediones. Cochran-Armitage trend tests were used to examine whether the use of treatment significantly increases or decreases as the number of arteries with CAD increases (P = 0.036 for diet alone; P < 0.0001 for insulin, for sulfonylureas, and for metformin; P = 0.002 for thiazolidinediones).

KW - Coronary artery disease

KW - Diabetes mellitus

KW - Diet

KW - Insulin

KW - Metformin

KW - Sulfonylureas

KW - Thiazolidinediones

UR - http://www.scopus.com/inward/record.url?scp=33748943490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748943490&partnerID=8YFLogxK

U2 - 10.1097/01.mjt.0000208276.65249.1b

DO - 10.1097/01.mjt.0000208276.65249.1b

M3 - Article

C2 - 16988534

AN - SCOPUS:33748943490

VL - 13

SP - 400

EP - 403

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 5

ER -